Cell therapy has produced some of the most effective cancer treatments of the past decade, and some of the least available.
CAR-T therapy is made from a patient’s own cells, which means a separate manufacturing run for every person treated, at a cost and a turnaround time that puts it out of reach for most patients.
The alternative is to make the therapy in advance from healthy donor cells, so that it can be taken off a shelf when a patient needs it.
That is what allogeneic cell therapy means, and it is the category East Ocyon Bio is working in.
Private Limited was founded in Gurugram in 2022 by Dinesh Kundu, who is chief executive and holds MBBS and MBA degrees, along with Renu Kundu and Narinder Mehra.
